Relaxin and the progression of kidney disease.

Relaxin and the progression of kidney disease.

Item
http://www.wikidata.org/entity/Q37349029
Relaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat ModelRelaxin abrogates renal interstitial fibrosis by regulating macrophage polarization via inhibition of Toll-like receptor 4 signaling.Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injuryRelaxin does not improve Angiotensin II-induced target-organ damage.Fibrosis in the kidney: is a problem shared a problem halved?Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHFRelationship of relaxin hormone and thumb carpometacarpal joint arthritis.Kidney aging--inevitable or preventable?Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.Recombinant human relaxin-2: (how) can a pregnancy hormone save lives in acute heart failure?Relaxin-mediated renal vasodilation in the rat is associated with falls in glomerular blood pressure.
P2860

Relaxin and the progression of kidney disease.

Item
http://www.wikidata.org/entity/Q37349029
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relaxin and the progression of kidney disease.
@en
Relaxin and the progression of kidney disease.
@nl
type
label
Relaxin and the progression of kidney disease.
@en
Relaxin and the progression of kidney disease.
@nl
prefLabel
Relaxin and the progression of kidney disease.
@en
Relaxin and the progression of kidney disease.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Relaxin and the progression of kidney disease
@en
P2093
P304
P31
P356
10.1097/MNH.0B013E32831B7096
P433
P478
P50
P577
P698